Free Trial

IDEX (IEX) Financials

IDEX logo
$183.36 +3.76 (+2.09%)
Closing price 03:59 PM Eastern
Extended Trading
$183.44 +0.09 (+0.05%)
As of 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for IDEX

Annual Income Statements for IDEX

This table shows IDEX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
505 596 587 449 378 426 411 337 271 283
Consolidated Net Income / (Loss)
505 596 587 449 378 426 411 337 271 283
Net Income / (Loss) Continuing Operations
505 596 587 449 378 426 411 337 271 283
Total Pre-Tax Income
639 760 749 580 470 533 529 455 369 392
Total Operating Income
677 733 751 637 521 579 569 493 435 419
Total Gross Profit
1,445 1,447 1,427 1,225 1,027 1,125 1,118 1,027 931 904
Total Revenue
3,269 3,274 3,182 2,765 2,352 2,495 2,484 2,287 2,113 2,021
Operating Revenue
3,269 3,274 3,182 2,765 2,352 2,495 2,484 2,287 2,113 2,021
Total Cost of Revenue
1,824 1,827 1,755 1,540 1,324 1,370 1,366 1,261 1,182 1,116
Operating Cost of Revenue
1,824 1,827 1,755 1,540 1,324 1,370 1,366 1,261 1,182 1,116
Total Operating Expenses
768 714 676 588 507 546 549 533 496 485
Selling, General & Admin Expense
759 704 653 578 495 525 537 525 492 474
Restructuring Charge
9.30 11 23 9.30 12 21 12 8.46 3.67 11
Total Other Income / (Expense), net
-38 28 -2.00 -57 -50 -46 -40 -38 -66 -27
Interest & Investment Income
-45 -52 -41 - - - - - - -
Other Income / (Expense), net
6.60 80 39 -16 -5.60 -1.80 3.99 6.88 -21 15
Income Tax Expense
135 165 163 131 93 107 118 118 97 110
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.40 -0.50 -0.20 -0.10 0.00 0.00 - - - -
Basic Earnings per Share
$6.66 $7.87 $7.74 $5.91 $4.98 $5.62 $5.36 $4.41 $3.57 $3.65
Weighted Average Basic Shares Outstanding
75.70M 75.60M 75.70M 76M 75.70M 75.60M 76.41M 76.23M 75.80M 77.13M
Diluted Earnings per Share
$6.64 $7.85 $7.71 $5.88 $4.94 $5.56 $5.29 $4.36 $3.53 $3.62
Weighted Average Diluted Shares Outstanding
75.90M 75.90M 76M 76.40M 76.40M 76.50M 77.56M 77.33M 76.76M 77.97M
Weighted Average Basic & Diluted Shares Outstanding
75.78M 75.64M 75.52M 76.12M 75.89M 76.21M 76.60M 76.50M 75.90M 77.50M
Cash Dividends to Common per Share
$2.76 $2.56 $2.40 $2.16 $2.00 $2.00 $1.72 $1.48 $1.36 $1.28

Quarterly Income Statements for IDEX

This table shows IDEX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
96 123 119 141 121 109 209 139 140 130 179
Consolidated Net Income / (Loss)
95 123 119 141 121 108 209 139 140 130 179
Net Income / (Loss) Continuing Operations
95 123 119 141 121 108 209 139 140 130 179
Total Pre-Tax Income
125 151 154 179 155 140 262 179 180 164 228
Total Operating Income
142 165 168 183 161 161 180 200 192 175 202
Total Gross Profit
369 367 354 367 357 337 350 378 383 346 382
Total Revenue
814 863 798 807 801 789 793 846 845 811 824
Operating Revenue
814 863 798 807 801 789 793 846 845 811 824
Total Cost of Revenue
445 496 444 440 443 452 444 468 463 465 442
Operating Cost of Revenue
445 496 444 440 443 452 444 468 463 465 442
Total Operating Expenses
227 202 186 184 196 176 170 178 190 171 180
Selling, General & Admin Expense
209 198 183 183 195 174 166 174 190 169 162
Restructuring Charge
18 3.90 3.00 1.30 1.10 2.70 4.10 3.60 0.50 1.70 18
Total Other Income / (Expense), net
-18 -14 -14 -3.50 -6.70 -20 82 -22 -13 -12 26
Interest & Investment Income
-16 - - - - - - - - - -
Other Income / (Expense), net
-1.40 2.60 -3.30 4.60 2.70 -8.70 96 -8.30 0.60 0.60 36
Income Tax Expense
29 28 36 38 33 32 53 40 40 34 50
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.10 - -0.20 -0.10 -0.10 -0.30 -0.10 -0.10 0.00 - 0.00
Basic Earnings per Share
$1.26 $1.63 $1.57 $1.86 $1.60 $1.43 $2.76 $1.83 $1.85 $1.71 $2.37
Weighted Average Basic Shares Outstanding
75.70M 75.70M 75.70M 75.70M 75.70M 75.60M 75.60M 75.60M 75.60M 75.70M 75.40M
Diluted Earnings per Share
$1.26 $1.61 $1.57 $1.86 $1.60 $1.44 $2.75 $1.82 $1.84 $1.71 $2.36
Weighted Average Diluted Shares Outstanding
75.80M 75.90M 75.90M 75.90M 75.90M 75.90M 75.90M 75.90M 75.90M 76M 75.80M
Weighted Average Basic & Diluted Shares Outstanding
75.54M 75.78M 75.72M 75.70M 75.70M 75.64M 75.63M 75.60M 75.58M 75.52M 75.42M

Annual Cash Flow Statements for IDEX

This table details how cash moves in and out of IDEX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
105 104 -425 -171 393 166 90 140 -92 -181
Net Cash From Operating Activities
668 717 557 565 569 528 479 433 400 360
Net Cash From Continuing Operating Activities
668 717 557 565 569 528 479 433 400 360
Net Income / (Loss) Continuing Operations
505 596 587 449 378 426 411 337 271 283
Consolidated Net Income / (Loss)
505 596 587 449 378 426 411 337 271 283
Depreciation Expense
69 57 51 47 42 40 39 38 38 36
Amortization Expense
107 95 69 56 44 39 40 47 50 44
Non-Cash Adjustments To Reconcile Net Income
22 -54 4.20 33 24 39 32 22 53 4.42
Changes in Operating Assets and Liabilities, net
-34 23 -153 -20 82 -14 -42 -12 -13 -6.64
Net Cash From Investing Activities
-1,007 -284 -917 -698 -173 -137 -81 -55 -509 -210
Net Cash From Continuing Investing Activities
-1,007 -284 -917 -698 -173 -137 -81 -55 -509 -210
Purchase of Property, Plant & Equipment
-65 -90 -68 -73 -52 -51 -56 -44 -38 -44
Acquisitions
-985 -312 -946 -577 -123 -87 -24 -38 -510 -195
Purchase of Investments
0.00 -29 0.00 -45 0.00 - - - - -
Divestitures
45 119 49 0.00 0.00 - 0.00 22 39 28
Sale and/or Maturity of Investments
4.50 25 40 0.00 0.00 - - - - -
Other Investing Activities, net
-6.50 3.50 7.30 -2.80 2.10 1.10 -1.50 5.48 -0.02 0.62
Net Cash From Financing Activities
466 -345 -38 -9.50 -43 -228 -290 -277 47 -296
Net Cash From Continuing Financing Activities
466 -345 -38 -9.50 -43 -228 -290 -277 47 -296
Repayment of Debt
-122 -251 -137 -355 -455 -52 -11 -201 -520 -424
Repurchase of Common Equity
0.00 -24 -148 0.00 -110 -55 -174 -29 -57 -211
Payment of Dividends
-205 -191 -177 -161 -152 -147 -127 -111 -103 -96
Issuance of Debt
776 100 410 499 649 - 0.00 33 702 414
Issuance of Common Equity
17 22 14 14 0.00 - - - - -
Other Net Changes in Cash
-23 - - -28 39 2.70 - - - -
Cash Interest Paid
47 51 37 36 35 37 36 37 37 34
Cash Income Taxes Paid
171 200 176 118 87 109 91 105 109 113

Quarterly Cash Flow Statements for IDEX

This table details how cash moves in and out of IDEX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-27 -12 -49 84 82 -28 106 -54 81 -251 123
Net Cash From Operating Activities
106 173 205 134 157 201 227 141 148 167 198
Net Cash From Continuing Operating Activities
106 173 205 134 157 201 227 141 148 167 198
Net Income / (Loss) Continuing Operations
95 123 119 141 121 108 209 139 140 130 179
Consolidated Net Income / (Loss)
95 123 119 141 121 108 209 139 140 130 179
Depreciation Expense
18 19 17 16 16 15 15 14 13 14 12
Amortization Expense
32 32 27 24 25 24 24 23 24 20 16
Non-Cash Adjustments To Reconcile Net Income
14 5.00 4.60 -0.20 13 13 -92 12 13 5.60 -13
Changes in Operating Assets and Liabilities, net
-53 -6.30 38 -48 -18 40 71 -47 -41 -1.80 3.40
Net Cash From Investing Activities
-10 -15 -1,004 32 -20 -194 87 -147 -29 -693 36
Net Cash From Continuing Investing Activities
-10 -15 -1,004 32 -20 -194 87 -147 -29 -693 36
Purchase of Property, Plant & Equipment
-14 -16 -14 -16 -20 -22 -20 -22 -27 -20 -16
Acquisitions
4.20 - -986 - - -202 - - - -713 2.30
Other Investing Activities, net
0.10 0.80 -7.80 0.50 0.00 0.60 1.90 0.40 0.60 0.50 6.90
Net Cash From Financing Activities
-133 -141 725 -77 -41 -58 -195 -47 -45 237 -78
Net Cash From Continuing Financing Activities
-133 -141 725 -77 -41 -58 -195 -47 -45 237 -78
Repayment of Debt
-30 -95 -1.40 -25 -0.20 -0.30 -151 -101 0.00 -97 -40
Repurchase of Common Equity
-50 - - - - -23 -0.10 - - -1.80 -36
Payment of Dividends
-52 -52 -52 -52 -49 -48 -48 -48 -46 -45 -45
Other Financing Activities, net
-0.50 - - - - - - - - - 3.60
Effect of Exchange Rate Changes
11 - 24 -3.70 -14 22 -13 -0.70 7.00 38 -33
Cash Interest Paid
16 22 2.50 21 2.40 20 5.40 21 4.10 18 0.40
Cash Income Taxes Paid
20 51 36 66 18 52 44 82 21 46 43

Annual Balance Sheets for IDEX

This table presents IDEX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
6,745 5,865 5,512 4,917 4,414 3,814 3,474 3,400 3,155 2,805
Total Current Assets
1,593 1,446 1,399 1,678 1,657 1,261 1,093 1,004 823 863
Cash & Equivalents
621 534 430 855 1,026 633 466 376 236 328
Accounts Receivable
466 428 443 356 293 298 312 294 273 260
Inventories, net
430 421 471 370 290 293 280 260 253 239
Other Current Assets
76 63 55 96 48 37 34 74 61 36
Plant, Property, & Equipment, net
460 430 382 327 298 280 281 258 248 241
Total Noncurrent Assets
4,692 3,989 3,731 2,912 2,459 2,272 2,100 2,137 2,084 1,702
Goodwill
3,252 2,838 2,638 2,168 1,896 1,780 1,698 1,704 1,633 1,397
Intangible Assets
1,285 1,012 948 597 416 388 383 415 436 288
Other Noncurrent Operating Assets
156 139 145 147 148 104 19 18 16 17
Total Liabilities & Shareholders' Equity
6,745 5,865 5,512 4,917 4,414 3,814 3,474 3,400 3,155 2,805
Total Liabilities
2,951 2,324 2,472 2,114 1,874 1,551 1,479 1,513 1,611 1,362
Total Current Liabilities
630 500 544 480 399 358 365 361 309 310
Short-Term Debt
101 0.60 0.00 - 0.10 0.39 0.48 - - -
Accounts Payable
198 180 209 179 152 138 143 147 129 129
Accrued Expenses
279 272 289 260 209 180 188 185 153 154
Dividends Payable
53 49 46 41 38 39 33 29 26 26
Total Noncurrent Liabilities
2,322 1,824 1,929 1,634 1,475 1,193 1,115 1,152 1,302 1,053
Long-Term Debt
1,860 1,325 1,469 1,190 1,044 849 848 859 1,014 840
Noncurrent Deferred & Payable Income Tax Liabilities
267 292 264 196 164 147 128 138 166 110
Other Noncurrent Operating Liabilities
195 207 196 247 267 197 138 156 121 102
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,794 3,541 3,040 2,803 2,540 2,263 1,995 1,887 1,544 1,443
Total Preferred & Common Equity
3,795 3,541 3,039 2,803 2,540 2,263 1,995 1,887 1,544 1,443
Preferred Stock
0.00 0.00 0.00 - 0.00 0.00 0.00 - - -
Total Common Equity
3,795 3,541 3,039 2,803 2,540 2,263 1,995 1,887 1,544 1,443
Common Stock
866 840 818 797 776 761 739 718 698 681
Retained Earnings
4,230 3,934 3,532 3,127 2,842 2,615 2,342 2,058 1,835 1,667
Treasury Stock
-1,170 -1,187 -1,184 -1,050 -1,064 -986 -957 -800 -787 -757
Accumulated Other Comprehensive Income / (Loss)
-131 -46 -126 -70 -14 -127 -129 -90 -202 -146
Noncontrolling Interest
-0.60 -0.20 0.30 0.00 0.10 0.00 - - - -

Quarterly Balance Sheets for IDEX

This table presents IDEX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets
6,795 6,745 6,968 5,903 5,889 5,865 5,670 5,720 5,658 5,512 4,893
Total Current Assets
1,627 1,593 1,678 1,630 1,555 1,446 1,518 1,488 1,525 1,399 1,635
Cash & Equivalents
594 621 633 701 616 534 563 457 511 430 681
Accounts Receivable
483 466 475 426 438 428 431 455 447 443 406
Inventories, net
466 430 488 428 426 421 447 483 498 471 455
Other Current Assets
84 76 81 75 74 63 78 93 70 55 93
Plant, Property, & Equipment, net
460 460 469 419 428 430 422 422 397 382 304
Total Noncurrent Assets
4,709 4,692 4,821 3,855 3,907 3,989 3,730 3,810 3,737 3,731 2,954
Goodwill
3,287 3,252 3,316 2,787 2,803 2,838 2,677 2,714 2,658 2,638 2,191
Intangible Assets
1,268 1,285 1,349 931 969 1,012 920 957 934 948 629
Other Noncurrent Operating Assets
154 156 156 137 135 139 133 139 145 145 134
Total Liabilities & Shareholders' Equity
6,795 6,745 6,968 5,903 5,889 5,865 5,670 5,720 5,658 5,512 4,893
Total Liabilities
2,889 2,951 3,149 2,250 2,271 2,324 2,282 2,441 2,429 2,472 2,090
Total Current Liabilities
584 630 565 477 461 500 488 487 492 544 507
Short-Term Debt
101 101 0.60 0.60 0.70 0.60 0.70 0.50 - 0.00 -
Accounts Payable
208 198 210 172 186 180 176 190 216 209 197
Accrued Expenses
275 279 301 252 274 272 262 248 276 289 265
Dividends Payable
0.00 53 52 52 0.00 49 49 49 0.00 46 45
Total Noncurrent Liabilities
2,306 2,322 2,585 1,773 1,811 1,824 1,795 1,954 1,937 1,929 1,584
Long-Term Debt
1,839 1,860 2,075 1,297 1,323 1,325 1,321 1,472 1,471 1,469 1,191
Noncurrent Deferred & Payable Income Tax Liabilities
273 267 301 281 286 292 279 286 267 264 186
Other Noncurrent Operating Liabilities
193 195 208 194 202 207 195 197 199 196 207
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,906 3,794 3,818 3,653 3,618 3,541 3,387 3,279 3,230 3,040 2,803
Total Preferred & Common Equity
3,907 3,795 3,819 3,654 3,619 3,541 3,387 3,279 3,229 3,039 2,803
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Total Common Equity
3,907 3,795 3,819 3,654 3,619 3,541 3,387 3,279 3,229 3,039 2,803
Common Stock
879 866 861 857 852 840 837 835 831 818 813
Retained Earnings
4,326 4,230 4,159 4,093 4,056 3,934 3,874 3,713 3,672 3,532 3,447
Treasury Stock
-1,221 -1,170 -1,177 -1,179 -1,179 -1,187 -1,178 -1,182 -1,184 -1,184 -1,193
Accumulated Other Comprehensive Income / (Loss)
-77 -131 -25 -116 -110 -46 -146 -88 -89 -126 -264
Noncontrolling Interest
-0.70 -0.60 -0.60 -0.40 -0.30 -0.20 0.10 0.20 0.30 0.30 -0.20

Annual Metrics And Ratios for IDEX

This table displays calculated financial ratios and metrics derived from IDEX's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
-0.16% 2.89% 15.09% 17.57% -5.73% 0.44% 8.58% 8.25% 4.57% -5.92%
EBITDA Growth
-10.86% 5.97% 25.70% 20.57% -8.42% 0.54% 11.31% 16.60% -2.22% 0.15%
EBIT Growth
-15.79% 2.77% 27.27% 20.52% -10.76% 0.72% 14.58% 20.77% -4.57% -0.08%
NOPAT Growth
-6.85% -2.46% 19.17% 18.01% -9.52% 4.66% 20.89% 14.26% 5.91% -1.64%
Net Income Growth
-15.28% 1.52% 30.58% 18.93% -11.21% 3.64% 21.74% 24.40% -4.14% 1.22%
EPS Growth
-15.41% 1.82% 31.12% 19.03% -11.15% 5.10% 21.33% 23.51% -2.49% 4.93%
Operating Cash Flow Growth
-6.78% 28.58% -1.40% -0.70% 7.80% 10.17% 10.77% 8.21% 10.99% -2.08%
Free Cash Flow Firm Growth
-185.45% 188.87% -301.05% -126.12% -4.02% -17.60% 35.86% 762.62% -126.71% -52.21%
Invested Capital Growth
18.37% 6.24% 29.70% 22.43% 3.11% 4.49% 0.50% 2.09% 18.54% 6.63%
Revenue Q/Q Growth
2.32% -0.66% 3.11% 3.75% 0.37% -0.32% 1.15% 2.49% 1.47% -1.18%
EBITDA Q/Q Growth
3.27% -1.80% 1.98% 4.15% 1.61% -0.83% 0.49% 8.90% -2.33% 0.88%
EBIT Q/Q Growth
2.41% -2.85% 1.65% 3.70% 1.50% -1.16% 0.93% 11.06% -3.31% 0.70%
NOPAT Q/Q Growth
1.99% -2.49% 2.33% 3.63% 0.39% 0.05% 2.51% 3.38% 5.92% -0.79%
Net Income Q/Q Growth
3.04% -3.52% 1.96% 4.08% 1.14% -0.31% 1.08% 12.10% -3.70% 2.22%
EPS Q/Q Growth
2.63% -3.33% 2.12% 4.26% 0.82% 0.00% 1.15% 12.08% -3.55% 2.55%
Operating Cash Flow Q/Q Growth
-4.08% 4.93% 0.76% 0.30% 1.82% -0.45% 3.77% 4.99% 4.45% -0.78%
Free Cash Flow Firm Q/Q Growth
54.53% 227.73% -196.86% -20.23% -2.89% -6.42% 9.96% -17.81% 65.94% -21.82%
Invested Capital Q/Q Growth
-2.39% 4.45% 22.79% 0.90% -0.15% -0.62% -1.64% -0.50% -3.79% -0.90%
Profitability Metrics
- - - - - - - - - -
Gross Margin
44.21% 44.20% 44.84% 44.29% 43.69% 45.10% 45.01% 44.89% 44.05% 44.75%
EBITDA Margin
26.29% 29.45% 28.59% 26.18% 25.53% 26.28% 26.25% 25.61% 23.77% 25.42%
Operating Margin
20.72% 22.37% 23.61% 23.04% 22.14% 23.21% 22.91% 21.57% 20.57% 20.73%
EBIT Margin
20.92% 24.80% 24.83% 22.45% 21.90% 23.14% 23.07% 21.87% 19.60% 21.48%
Profit (Net Income) Margin
15.44% 18.19% 18.44% 16.25% 16.07% 17.06% 16.53% 14.74% 12.83% 14.00%
Tax Burden Percent
78.93% 78.34% 78.29% 77.49% 80.33% 79.85% 77.62% 74.08% 73.57% 72.08%
Interest Burden Percent
93.49% 93.63% 94.85% 93.40% 91.30% 92.33% 92.30% 91.03% 88.99% 90.41%
Effective Tax Rate
21.07% 21.66% 21.71% 22.51% 19.67% 20.15% 22.38% 25.92% 26.43% 27.92%
Return on Invested Capital (ROIC)
11.17% 13.49% 16.11% 17.09% 16.35% 18.76% 18.37% 15.39% 14.77% 15.72%
ROIC Less NNEP Spread (ROIC-NNEP)
8.49% 15.76% 15.90% -3.38% -9.59% 7.79% 11.65% 11.12% 7.52% 11.52%
Return on Net Nonoperating Assets (RNNOA)
2.58% 4.61% 3.97% -0.27% -0.62% 1.23% 2.79% 4.27% 3.39% 3.58%
Return on Equity (ROE)
13.76% 18.10% 20.08% 16.82% 15.73% 19.99% 21.16% 19.66% 18.15% 19.31%
Cash Return on Invested Capital (CROIC)
-5.65% 7.44% -9.75% -3.07% 13.29% 14.37% 17.88% 13.33% -2.20% 9.31%
Operating Return on Assets (OROA)
10.84% 14.27% 15.15% 13.31% 12.52% 15.84% 16.67% 15.26% 13.90% 15.20%
Return on Assets (ROA)
8.00% 10.47% 11.25% 9.63% 9.18% 11.68% 11.95% 10.29% 9.10% 9.91%
Return on Common Equity (ROCE)
13.76% 18.10% 20.08% 16.82% 15.73% 19.99% 21.16% 19.66% 18.15% 19.31%
Return on Equity Simple (ROE_SIMPLE)
13.30% 16.82% 19.30% 16.03% 14.87% 18.80% 20.58% 17.88% 17.56% 19.59%
Net Operating Profit after Tax (NOPAT)
535 574 588 494 418 462 442 365 320 302
NOPAT Margin
16.35% 17.53% 18.49% 17.85% 17.79% 18.53% 17.79% 15.98% 15.13% 14.94%
Net Nonoperating Expense Percent (NNEP)
2.68% -2.26% 0.21% 20.47% 25.94% 10.97% 6.72% 4.27% 7.24% 4.21%
Return On Investment Capital (ROIC_SIMPLE)
9.29% 11.79% 13.05% - - - - - - -
Cost of Revenue to Revenue
55.79% 55.81% 55.16% 55.71% 56.31% 54.90% 54.99% 55.11% 55.95% 55.25%
SG&A Expenses to Revenue
23.21% 21.49% 20.51% 20.91% 21.05% 21.05% 21.61% 22.95% 23.30% 23.47%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.49% 21.82% 21.23% 21.25% 21.55% 21.89% 22.10% 23.32% 23.48% 24.02%
Earnings before Interest and Taxes (EBIT)
684 812 790 621 515 577 573 500 414 434
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
859 964 910 724 600 656 652 586 502 514
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
4.16 4.56 5.51 6.20 5.69 5.47 4.54 4.93 4.05 3.64
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 456.23 63.08 129.71 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
4.83 4.94 5.26 6.29 6.14 4.96 3.64 4.07 2.96 2.60
Price to Earnings (P/E)
31.28 27.11 28.54 38.68 38.24 29.10 22.05 27.60 23.07 18.57
Dividend Yield
1.30% 1.18% 1.05% 0.93% 1.05% 1.19% 1.41% 1.19% 1.63% 1.81%
Earnings Yield
3.20% 3.69% 3.50% 2.59% 2.62% 3.44% 4.54% 3.62% 4.33% 5.38%
Enterprise Value to Invested Capital (EV/IC)
3.30 3.87 4.31 5.57 5.57 5.00 3.91 4.08 2.99 2.91
Enterprise Value to Revenue (EV/Rev)
5.24 5.18 5.59 6.41 6.15 5.05 3.80 4.28 3.33 2.85
Enterprise Value to EBITDA (EV/EBITDA)
19.94 17.58 19.55 24.48 24.09 19.22 14.47 16.72 14.00 11.22
Enterprise Value to EBIT (EV/EBIT)
25.06 20.87 22.52 28.54 28.08 21.83 16.46 19.58 16.98 13.28
Enterprise Value to NOPAT (EV/NOPAT)
32.06 29.54 30.24 35.89 34.58 27.25 21.36 26.80 21.99 19.09
Enterprise Value to Operating Cash Flow (EV/OCF)
25.65 23.65 31.91 31.34 25.41 23.85 19.68 22.63 17.59 16.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 53.56 0.00 0.00 42.55 35.57 21.95 30.95 0.00 32.25
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.52 0.37 0.48 0.42 0.41 0.38 0.43 0.46 0.66 0.58
Long-Term Debt to Equity
0.49 0.37 0.48 0.42 0.41 0.38 0.43 0.46 0.66 0.58
Financial Leverage
0.30 0.29 0.25 0.08 0.07 0.16 0.24 0.38 0.45 0.31
Leverage Ratio
1.72 1.73 1.79 1.75 1.71 1.71 1.77 1.91 2.00 1.95
Compound Leverage Factor
1.61 1.62 1.69 1.63 1.56 1.58 1.63 1.74 1.78 1.76
Debt to Total Capital
34.07% 27.24% 32.58% 29.81% 29.14% 27.29% 29.85% 31.28% 39.65% 36.78%
Short-Term Debt to Total Capital
1.75% 0.01% 0.00% 0.00% 0.00% 0.01% 0.02% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
32.32% 27.23% 32.58% 29.81% 29.13% 27.27% 29.83% 31.28% 39.65% 36.78%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.01% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
65.95% 72.77% 67.42% 70.19% 70.86% 72.71% 70.15% 68.72% 60.35% 63.22%
Debt to EBITDA
2.28 1.38 1.61 1.64 1.74 1.30 1.30 1.47 2.02 1.63
Net Debt to EBITDA
1.56 0.82 1.14 0.46 0.03 0.33 0.59 0.82 1.55 1.00
Long-Term Debt to EBITDA
2.16 1.37 1.61 1.64 1.74 1.30 1.30 1.47 2.02 1.63
Debt to NOPAT
3.67 2.31 2.50 2.41 2.50 1.84 1.92 2.35 3.17 2.78
Net Debt to NOPAT
2.51 1.38 1.77 0.68 0.04 0.47 0.87 1.32 2.43 1.69
Long-Term Debt to NOPAT
3.48 2.31 2.50 2.41 2.50 1.84 1.92 2.35 3.17 2.78
Altman Z-Score
5.08 6.32 6.20 7.09 6.79 7.19 6.13 5.92 4.44 4.61
Noncontrolling Interest Sharing Ratio
-0.01% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.53 2.89 2.57 3.50 4.15 3.52 3.00 2.78 2.66 2.79
Quick Ratio
1.73 1.92 1.61 2.52 3.31 2.60 2.14 1.86 1.65 1.90
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-270 316 -356 -89 340 354 430 316 -48 179
Operating Cash Flow to CapEx
1,026.27% 797.22% 819.71% 777.58% 1,103.29% 1,037.52% 860.18% 986.71% 1,045.75% 823.10%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 -2.17 7.59 7.99 9.74 7.05 -1.05 4.29
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 13.79 12.71 11.92 10.86 9.64 8.77 8.65
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 12.01 11.56 10.77 9.60 8.66 7.93 7.60
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.52 0.58 0.61 0.59 0.57 0.68 0.72 0.70 0.71 0.71
Accounts Receivable Turnover
7.32 7.52 7.96 8.51 7.95 8.17 8.19 8.07 7.93 7.83
Inventory Turnover
4.29 4.10 4.17 4.67 4.54 4.78 5.06 4.92 4.81 4.68
Fixed Asset Turnover
7.34 8.06 8.97 8.84 8.13 8.88 9.21 9.04 8.65 8.78
Accounts Payable Turnover
9.66 9.40 9.05 9.31 9.12 9.73 9.41 9.14 9.17 8.71
Days Sales Outstanding (DSO)
49.90 48.53 45.84 42.87 45.89 44.65 44.56 45.24 46.02 46.61
Days Inventory Outstanding (DIO)
85.12 89.07 87.49 78.23 80.40 76.41 72.12 74.21 75.94 77.94
Days Payable Outstanding (DPO)
37.78 38.82 40.32 39.19 40.03 37.53 38.79 39.96 39.80 41.91
Cash Conversion Cycle (CCC)
97.23 98.79 93.01 81.91 86.26 83.54 77.89 79.49 82.16 82.63
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
5,186 4,381 4,124 3,179 2,597 2,519 2,410 2,399 2,350 1,982
Invested Capital Turnover
0.68 0.77 0.87 0.96 0.92 1.01 1.03 0.96 0.98 1.05
Increase / (Decrease) in Invested Capital
805 257 944 582 78 108 12 49 368 123
Enterprise Value (EV)
17,137 16,949 17,789 17,717 14,464 12,598 9,434 9,793 7,033 5,765
Market Capitalization
15,798 16,158 16,750 17,382 14,445 12,381 9,052 9,310 6,255 5,253
Book Value per Share
$50.11 $46.83 $40.30 $36.87 $33.55 $29.76 $26.00 $24.69 $20.25 $18.86
Tangible Book Value per Share
($9.80) ($4.08) ($7.25) $0.50 $3.02 $1.26 ($1.13) ($3.04) ($6.88) ($3.15)
Total Capital
5,754 4,867 4,508 3,993 3,585 3,112 2,843 2,745 2,558 2,283
Total Debt
1,960 1,326 1,469 1,190 1,045 849 849 859 1,014 840
Total Long-Term Debt
1,860 1,325 1,469 1,190 1,044 849 848 859 1,014 840
Net Debt
1,339 791 1,039 335 19 217 382 483 778 512
Capital Expenditures (CapEx)
65 90 68 73 52 51 56 44 38 44
Debt-free, Cash-free Net Working Capital (DFCFNWC)
443 412 426 343 232 271 262 267 278 225
Debt-free Net Working Capital (DFNWC)
1,064 947 856 1,198 1,258 904 728 643 514 553
Net Working Capital (NWC)
963 946 856 1,198 1,258 904 728 643 514 553
Net Nonoperating Expense (NNE)
30 -22 1.57 44 40 37 31 28 49 19
Net Nonoperating Obligations (NNO)
1,392 840 1,084 376 57 255 416 512 806 539
Total Depreciation and Amortization (D&A)
176 152 120 103 85 78 79 86 88 80
Debt-free, Cash-free Net Working Capital to Revenue
13.55% 12.59% 13.37% 12.39% 9.88% 10.88% 10.55% 11.68% 13.14% 11.14%
Debt-free Net Working Capital to Revenue
32.54% 28.91% 26.89% 43.33% 53.51% 36.24% 29.33% 28.11% 24.30% 27.37%
Net Working Capital to Revenue
29.46% 28.90% 26.89% 43.33% 53.50% 36.22% 29.31% 28.11% 24.30% 27.37%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$6.66 $7.87 $7.74 $5.91 $4.98 $5.62 $5.36 $4.41 $3.57 $3.65
Adjusted Weighted Average Basic Shares Outstanding
75.70M 75.60M 75.70M 76M 75.74M 75.59M 76.41M 76.23M 75.80M 77.13M
Adjusted Diluted Earnings per Share
$6.64 $7.85 $7.71 $5.88 $4.94 $5.56 $5.29 $4.36 $3.53 $3.62
Adjusted Weighted Average Diluted Shares Outstanding
75.90M 75.90M 76M 76.40M 76.40M 76.45M 77.56M 77.33M 76.76M 77.97M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
75.78M 75.64M 75.52M 76.12M 75.89M 76.21M 75.79M 76.54M 76.25M 75.93M
Normalized Net Operating Profit after Tax (NOPAT)
542 582 606 501 428 479 451 372 323 310
Normalized NOPAT Margin
16.58% 17.79% 19.05% 18.11% 18.19% 19.20% 18.16% 16.25% 15.26% 15.34%
Pre Tax Income Margin
19.56% 23.22% 23.55% 20.97% 20.00% 21.36% 21.30% 19.90% 17.44% 19.42%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 15.14 11.50 13.03 12.98 11.14 9.08 10.42
NOPAT to Interest Expense
0.00 0.00 0.00 12.04 9.34 10.44 10.01 8.14 7.01 7.25
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 13.37 10.35 11.88 11.72 10.17 8.24 9.37
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 10.27 8.19 9.29 8.75 7.16 6.17 6.20
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
40.69% 32.02% 30.24% 35.86% 40.18% 34.59% 31.05% 32.96% 37.86% 34.01%
Augmented Payout Ratio
40.69% 36.08% 55.48% 35.86% 69.38% 47.45% 73.41% 41.58% 58.99% 108.55%

Quarterly Metrics And Ratios for IDEX

This table displays calculated financial ratios and metrics derived from IDEX's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.72% 9.38% 0.61% -4.61% -5.31% -2.69% -3.71% 6.29% 12.55% 13.42% 15.73%
EBITDA Growth
-6.94% 14.21% -33.57% -0.83% -10.73% -8.46% 17.82% 6.01% 5.28% 9.25% 41.76%
EBIT Growth
-14.22% 10.61% -40.22% -2.35% -15.03% -13.55% 15.76% 2.79% 1.58% 7.86% 48.19%
NOPAT Growth
-14.03% 8.64% -9.77% -7.28% -15.36% -10.90% -9.37% 6.70% 2.77% 10.86% 28.17%
Net Income Growth
-21.35% 13.76% -43.11% 1.95% -13.23% -16.69% 16.96% 0.29% -0.07% 9.52% 54.45%
EPS Growth
-21.25% 11.81% -42.91% 2.20% -13.04% -15.79% 16.53% 0.55% 0.55% 10.32% 56.29%
Operating Cash Flow Growth
-32.50% -14.13% -9.40% -5.38% 5.88% 20.14% 14.39% 25.73% 85.57% 2.58% 26.50%
Free Cash Flow Firm Growth
-8,466.17% -402.34% -42.80% 125.44% 98.60% 83.43% -1,311.54% -447.84% -32.93% -76.23% 88.50%
Invested Capital Growth
21.41% 18.37% 26.67% -0.91% 3.25% 6.24% 24.90% 25.27% 24.83% 29.70% 6.58%
Revenue Q/Q Growth
-5.63% 8.11% -1.12% 0.84% 1.47% -0.57% -6.24% 0.09% 4.28% -1.61% 3.50%
EBITDA Q/Q Growth
-12.85% 4.79% -8.31% 11.14% 6.95% -39.04% 36.88% 0.04% 9.66% -21.54% 23.15%
EBIT Q/Q Growth
-16.26% 1.94% -12.07% 14.28% 7.97% -44.90% 43.64% -0.57% 9.85% -26.22% 27.55%
NOPAT Q/Q Growth
-19.21% 4.11% -10.13% 13.75% 2.08% -13.53% -7.65% 3.84% 7.46% -12.05% 8.72%
Net Income Q/Q Growth
-22.56% 3.62% -15.79% 16.41% 12.00% -48.18% 50.90% -0.93% 7.54% -27.25% 29.40%
EPS Q/Q Growth
-21.74% 2.55% -15.59% 16.25% 11.11% -47.64% 51.10% -1.09% 7.60% -27.54% 30.39%
Operating Cash Flow Q/Q Growth
-38.76% -15.93% 53.67% -14.69% -22.09% -11.30% 60.48% -4.53% -11.60% -15.55% 76.40%
Free Cash Flow Firm Q/Q Growth
-21.93% 32.26% -639.56% 2,022.04% 92.85% 80.74% 3.86% -5.41% 15.09% -1,540.40% 62.69%
Invested Capital Q/Q Growth
1.26% -2.39% 23.48% -0.52% -1.27% 4.45% -3.41% 3.65% 1.60% 22.79% -3.12%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
45.30% 42.54% 44.34% 45.44% 44.65% 42.69% 44.06% 44.67% 45.24% 42.64% 46.34%
EBITDA Margin
23.39% 25.33% 26.13% 28.18% 25.57% 24.26% 39.58% 27.11% 27.12% 25.79% 32.34%
Operating Margin
17.44% 19.16% 21.05% 22.63% 20.14% 20.34% 22.64% 23.65% 22.75% 21.59% 24.54%
EBIT Margin
17.27% 19.46% 20.63% 23.20% 20.47% 19.24% 34.72% 22.67% 22.82% 21.66% 28.88%
Profit (Net Income) Margin
11.72% 14.28% 14.90% 17.49% 15.15% 13.73% 26.34% 16.37% 16.54% 16.04% 21.69%
Tax Burden Percent
76.63% 81.48% 77.01% 78.79% 78.51% 77.25% 79.83% 77.59% 77.75% 79.51% 78.24%
Interest Burden Percent
88.55% 90.05% 93.75% 95.68% 94.26% 92.36% 95.03% 93.07% 93.21% 93.11% 95.97%
Effective Tax Rate
23.37% 18.52% 22.99% 21.21% 21.49% 22.75% 20.17% 22.41% 22.25% 20.49% 21.76%
Return on Invested Capital (ROIC)
9.16% 10.67% 10.89% 13.16% 11.99% 12.10% 15.77% 15.63% 15.36% 14.96% 18.20%
ROIC Less NNEP Spread (ROIC-NNEP)
7.85% 9.64% 9.98% 12.84% 11.36% 10.47% 25.40% 13.71% 13.99% 13.70% 22.39%
Return on Net Nonoperating Assets (RNNOA)
2.14% 2.93% 3.19% 3.17% 2.77% 3.06% 5.59% 3.94% 3.23% 3.43% 3.97%
Return on Equity (ROE)
11.30% 13.60% 14.08% 16.33% 14.76% 15.16% 21.36% 19.57% 18.59% 18.38% 22.17%
Cash Return on Invested Capital (CROIC)
-8.54% -5.65% -12.51% 13.38% 9.74% 7.44% -6.56% -7.01% -6.38% -9.75% 11.29%
Operating Return on Assets (OROA)
8.94% 10.09% 10.43% 12.74% 11.45% 11.07% 21.67% 14.18% 14.03% 13.22% 18.29%
Return on Assets (ROA)
6.06% 7.40% 7.53% 9.60% 8.47% 7.90% 16.44% 10.24% 10.17% 9.78% 13.73%
Return on Common Equity (ROCE)
11.30% 13.60% 14.08% 16.33% 14.76% 15.16% 21.36% 19.57% 18.59% 18.38% 22.17%
Return on Equity Simple (ROE_SIMPLE)
12.25% 0.00% 12.82% 15.87% 15.95% 0.00% 18.23% 17.90% 18.17% 0.00% 20.53%
Net Operating Profit after Tax (NOPAT)
109 135 129 144 127 124 143 155 150 139 158
NOPAT Margin
13.36% 15.61% 16.21% 17.83% 15.81% 15.72% 18.07% 18.35% 17.69% 17.16% 19.20%
Net Nonoperating Expense Percent (NNEP)
1.31% 1.03% 0.91% 0.32% 0.63% 1.63% -9.63% 1.92% 1.37% 1.25% -4.18%
Return On Investment Capital (ROIC_SIMPLE)
1.86% 2.34% - - - 2.55% - - - 3.09% -
Cost of Revenue to Revenue
54.70% 57.46% 55.66% 54.56% 55.35% 57.31% 55.94% 55.33% 54.76% 57.36% 53.67%
SG&A Expenses to Revenue
25.72% 22.93% 22.91% 22.65% 24.37% 22.01% 20.91% 20.60% 22.44% 20.85% 19.65%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
27.86% 23.39% 23.29% 22.81% 24.51% 22.35% 21.43% 21.02% 22.50% 21.06% 21.80%
Earnings before Interest and Taxes (EBIT)
141 168 165 187 164 152 276 192 193 176 238
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
191 219 209 228 205 191 314 229 229 209 267
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.51 4.16 4.24 4.15 5.07 4.56 4.57 4.89 5.30 5.51 5.25
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
4.18 4.83 5.07 4.76 5.68 4.94 4.70 4.82 5.23 5.26 4.77
Price to Earnings (P/E)
28.63 31.28 33.00 26.15 31.74 27.11 25.07 27.28 29.19 28.54 25.57
Dividend Yield
1.53% 1.30% 1.24% 1.62% 1.06% 1.18% 1.21% 1.15% 1.06% 1.05% 1.17%
Earnings Yield
3.49% 3.20% 3.03% 3.82% 3.15% 3.69% 3.99% 3.67% 3.43% 3.50% 3.91%
Enterprise Value to Invested Capital (EV/IC)
2.87 3.30 3.32 3.67 4.40 3.87 3.87 3.92 4.32 4.31 4.54
Enterprise Value to Revenue (EV/Rev)
4.59 5.24 5.52 4.95 5.90 5.18 4.93 5.12 5.52 5.59 4.94
Enterprise Value to EBITDA (EV/EBITDA)
17.82 19.94 21.18 16.82 20.27 17.58 16.54 18.23 19.63 19.55 17.08
Enterprise Value to EBIT (EV/EBIT)
22.80 25.06 26.40 20.26 24.32 20.87 19.43 21.34 22.80 22.52 19.60
Enterprise Value to NOPAT (EV/NOPAT)
29.13 32.06 33.63 29.26 34.58 29.54 27.59 28.28 30.53 30.24 26.50
Enterprise Value to Operating Cash Flow (EV/OCF)
24.40 25.65 25.31 21.98 26.25 23.65 23.77 26.02 28.91 31.91 27.54
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 27.27 45.93 53.56 0.00 0.00 0.00 0.00 41.44
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.50 0.52 0.54 0.36 0.37 0.37 0.39 0.45 0.46 0.48 0.43
Long-Term Debt to Equity
0.47 0.49 0.54 0.36 0.37 0.37 0.39 0.45 0.46 0.48 0.43
Financial Leverage
0.27 0.30 0.32 0.25 0.24 0.29 0.22 0.29 0.23 0.25 0.18
Leverage Ratio
1.69 1.72 1.75 1.68 1.69 1.73 1.71 1.75 1.74 1.79 1.76
Compound Leverage Factor
1.49 1.55 1.64 1.60 1.59 1.60 1.62 1.63 1.62 1.66 1.69
Debt to Total Capital
33.18% 34.07% 35.22% 26.21% 26.78% 27.24% 28.07% 30.98% 31.29% 32.58% 29.82%
Short-Term Debt to Total Capital
1.72% 1.75% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
31.46% 32.32% 35.21% 26.20% 26.77% 27.23% 28.05% 30.97% 31.29% 32.58% 29.82%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.01% -0.01% -0.01% -0.01% -0.01% 0.00% 0.00% 0.00% 0.01% 0.01% -0.01%
Common Equity to Total Capital
66.83% 65.95% 64.79% 73.79% 73.22% 72.77% 71.93% 69.01% 68.70% 67.42% 70.18%
Debt to EBITDA
2.30 2.28 2.49 1.38 1.41 1.38 1.35 1.58 1.60 1.61 1.34
Net Debt to EBITDA
1.59 1.56 1.73 0.64 0.75 0.82 0.77 1.09 1.04 1.14 0.57
Long-Term Debt to EBITDA
2.18 2.16 2.49 1.38 1.41 1.37 1.35 1.58 1.60 1.61 1.34
Debt to NOPAT
3.75 3.67 3.96 2.41 2.40 2.31 2.25 2.44 2.48 2.50 2.07
Net Debt to NOPAT
2.60 2.51 2.75 1.11 1.28 1.38 1.29 1.69 1.62 1.77 0.89
Long-Term Debt to NOPAT
3.56 3.48 3.96 2.41 2.40 2.31 2.24 2.44 2.48 2.50 2.07
Altman Z-Score
4.47 4.83 4.65 5.90 6.67 5.95 5.99 5.75 6.05 5.83 6.28
Noncontrolling Interest Sharing Ratio
-0.01% -0.01% -0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.79 2.53 2.97 3.41 3.37 2.89 3.11 3.06 3.10 2.57 3.23
Quick Ratio
1.84 1.73 1.96 2.36 2.29 1.92 2.04 1.87 1.95 1.61 2.15
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-817 -670 -989 183 -9.54 -133 -693 -721 -684 -805 -49
Operating Cash Flow to CapEx
739.16% 1,113.55% 1,498.54% 840.25% 783.00% 930.56% 1,127.36% 653.70% 556.02% 836.50% 1,215.34%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -96.05 22.64 -1.01 0.00 -50.57 -54.18 -52.19 0.00 -5.11
Operating Cash Flow to Interest Expense
0.00 0.00 19.93 16.49 16.66 0.00 16.54 10.62 11.29 0.00 20.64
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 18.60 14.53 14.53 0.00 15.07 8.99 9.26 0.00 18.94
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.52 0.52 0.51 0.55 0.56 0.58 0.62 0.63 0.61 0.61 0.63
Accounts Receivable Turnover
7.13 7.32 7.05 7.24 7.30 7.52 7.88 7.55 7.64 7.96 7.99
Inventory Turnover
4.09 4.29 3.81 3.91 3.91 4.10 4.08 3.91 3.91 4.17 4.18
Fixed Asset Turnover
7.39 7.34 7.18 7.59 7.83 8.06 9.09 8.93 9.07 8.97 9.98
Accounts Payable Turnover
9.27 9.66 9.21 9.83 9.00 9.40 9.87 9.10 8.49 9.05 9.08
Days Sales Outstanding (DSO)
51.18 49.90 51.74 50.42 49.99 48.53 46.33 48.33 47.78 45.84 45.71
Days Inventory Outstanding (DIO)
89.19 85.12 95.85 93.37 93.27 89.07 89.46 93.31 93.41 87.49 87.36
Days Payable Outstanding (DPO)
39.39 37.78 39.65 37.14 40.58 38.82 36.99 40.12 42.99 40.32 40.21
Cash Conversion Cycle (CCC)
100.97 97.23 107.94 106.66 102.68 98.79 98.80 101.52 98.20 93.01 92.85
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,252 5,186 5,313 4,303 4,326 4,381 4,195 4,342 4,190 4,124 3,358
Invested Capital Turnover
0.69 0.68 0.67 0.74 0.76 0.77 0.87 0.85 0.87 0.87 0.95
Increase / (Decrease) in Invested Capital
926 805 1,119 -39 136 257 836 876 833 944 207
Enterprise Value (EV)
15,060 17,137 17,627 15,775 19,042 16,949 16,237 17,032 18,085 17,789 15,233
Market Capitalization
13,715 15,798 16,185 15,178 18,335 16,158 15,478 16,017 17,125 16,750 14,723
Book Value per Share
$51.55 $50.11 $50.45 $48.27 $47.80 $46.83 $44.80 $43.38 $42.76 $40.30 $37.14
Tangible Book Value per Share
($8.56) ($9.80) ($11.18) ($0.85) ($2.03) ($4.08) ($2.78) ($5.20) ($4.80) ($7.25) ($0.23)
Total Capital
5,846 5,754 5,894 4,951 4,942 4,867 4,709 4,751 4,700 4,508 3,994
Total Debt
1,940 1,960 2,076 1,298 1,324 1,326 1,322 1,472 1,471 1,469 1,191
Total Long-Term Debt
1,839 1,860 2,075 1,297 1,323 1,325 1,321 1,472 1,471 1,469 1,191
Net Debt
1,346 1,339 1,443 597 707 791 759 1,015 960 1,039 510
Capital Expenditures (CapEx)
14 16 14 16 20 22 20 22 27 20 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)
550 443 481 452 478 412 469 545 522 426 448
Debt-free Net Working Capital (DFNWC)
1,144 1,064 1,114 1,153 1,095 947 1,031 1,002 1,033 856 1,129
Net Working Capital (NWC)
1,043 963 1,113 1,152 1,094 946 1,031 1,001 1,033 856 1,129
Net Nonoperating Expense (NNE)
13 11 10 2.76 5.26 16 -66 17 9.72 9.14 -20
Net Nonoperating Obligations (NNO)
1,346 1,392 1,495 650 707 840 807 1,064 960 1,084 556
Total Depreciation and Amortization (D&A)
50 51 44 40 41 40 39 38 36 34 29
Debt-free, Cash-free Net Working Capital to Revenue
16.75% 13.55% 15.04% 14.17% 14.81% 12.59% 14.22% 16.38% 15.93% 13.37% 14.51%
Debt-free Net Working Capital to Revenue
34.84% 32.54% 34.86% 36.13% 33.90% 28.91% 31.30% 30.12% 31.52% 26.89% 36.57%
Net Working Capital to Revenue
31.78% 29.46% 34.84% 36.12% 33.88% 28.90% 31.27% 30.10% 31.52% 26.89% 36.57%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.26 $1.63 $1.57 $1.86 $1.60 $1.43 $2.76 $1.83 $1.85 $1.71 $2.37
Adjusted Weighted Average Basic Shares Outstanding
75.70M 75.70M 75.70M 75.70M 75.70M 75.60M 75.60M 75.60M 75.60M 75.70M 75.40M
Adjusted Diluted Earnings per Share
$1.26 $1.61 $1.57 $1.86 $1.60 $1.44 $2.75 $1.82 $1.84 $1.71 $2.36
Adjusted Weighted Average Diluted Shares Outstanding
75.80M 75.90M 75.90M 75.90M 75.90M 75.90M 75.90M 75.90M 75.90M 76M 75.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
75.54M 75.78M 75.72M 75.70M 75.70M 75.64M 75.63M 75.60M 75.58M 75.52M 75.42M
Normalized Net Operating Profit after Tax (NOPAT)
122 138 132 145 127 126 147 158 150 140 172
Normalized NOPAT Margin
15.01% 15.98% 16.50% 17.96% 15.92% 15.98% 18.48% 18.68% 17.73% 17.33% 20.88%
Pre Tax Income Margin
15.29% 17.52% 19.34% 22.20% 19.30% 17.77% 33.00% 21.09% 21.27% 20.17% 27.72%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 15.99 23.12 17.44 0.00 20.11 14.42 14.73 0.00 24.79
NOPAT to Interest Expense
0.00 0.00 12.56 17.77 13.46 0.00 10.47 11.67 11.41 0.00 16.48
EBIT Less CapEx to Interest Expense
0.00 0.00 14.66 21.16 15.31 0.00 18.64 12.80 12.69 0.00 23.09
NOPAT Less CapEx to Interest Expense
0.00 0.00 11.23 15.81 11.34 0.00 9.00 10.05 9.38 0.00 14.78
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
43.70% 40.69% 41.13% 34.06% 33.56% 32.02% 30.37% 31.41% 30.94% 30.24% 30.07%
Augmented Payout Ratio
54.15% 40.69% 45.84% 38.06% 33.56% 36.08% 30.84% 38.01% 30.94% 55.48% 55.49%

Frequently Asked Questions About IDEX's Financials

When does IDEX's fiscal year end?

According to the most recent income statement we have on file, IDEX's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has IDEX's net income changed over the last 9 years?

IDEX's net income appears to be on an upward trend, with a most recent value of $504.60 million in 2024, rising from $282.81 million in 2015. The previous period was $595.60 million in 2023. View IDEX's forecast to see where analysts expect IDEX to go next.

What is IDEX's operating income?
IDEX's total operating income in 2024 was $677.20 million, based on the following breakdown:
  • Total Gross Profit: $1.45 billion
  • Total Operating Expenses: $768 million
How has IDEX revenue changed over the last 9 years?

Over the last 9 years, IDEX's total revenue changed from $2.02 billion in 2015 to $3.27 billion in 2024, a change of 61.8%.

How much debt does IDEX have?

IDEX's total liabilities were at $2.95 billion at the end of 2024, a 27.0% increase from 2023, and a 116.7% increase since 2015.

How much cash does IDEX have?

In the past 9 years, IDEX's cash and equivalents has ranged from $235.96 million in 2016 to $1.03 billion in 2020, and is currently $620.80 million as of their latest financial filing in 2024.

How has IDEX's book value per share changed over the last 9 years?

Over the last 9 years, IDEX's book value per share changed from 18.86 in 2015 to 50.11 in 2024, a change of 165.7%.



This page (NYSE:IEX) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners